IDXX vs A — Key Metrics

Metric IDXX (IDEXX LABORATORIES INC) A (AGILENT TECHNOLOGIES INC)
Price698.47177.33
Market Cap55.03 Billion49.99 Billion
P/E (TTM)46.8134.77
P/B (Quarterly)28.315.741
P/S (TTM)11.86.78
Net Profit Margin (TTM)25.419.5
Gross Margin (TTM)62.753.8
ROE (TTM)71.220.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

IDEXX LABORATORIES INC
vs
 
AGILENT TECHNOLOGIES INC
 
IDEXX LABORATORIES INC
vs
 
AGILENT TECHNOLOGIES INC
Performance Comparison
AI Model Recommendation
IDXX · IDEXX LABORATORIES INC

Greatly Underperform

-98
UnderperformOutperform
A · AGILENT TECHNOLOGIES INC

Underperform

-57
UnderperformOutperform
Recommendation Summary

Stock IDXX is projected to greatly underperform the market, stock A is projected to underperform the market. Upfront Recommendation: A.

Financial Metrics
Prices delayed ~15 min
IDXX Metrics A
$698.47 Price $177.33
— Market Capitalization —
46.81 Price to Earnings Ratio 34.77
11.8 Price to Sales 6.78
42.65 Price to FCF Ratio 39.46
18.82 Price to Gross Profit 12.6
206.21 Price to R&D 103.08
36.69 Price to Current Assets 10.65

IDXX vs A at a glance

Idexx Laboratories INC (IDXX) and Agilent Technologies INC (A) are both Diagnostics & Research companies in the Healthcare sector. They are similar in size: $55.0 billion and $50.0 billion in market value.

On trailing-twelve-month figures, IDXX trades at 46.8 times trailing earnings and A at 34.8; net profit margins are 25.4% and 19.5%.

The Upfront Investment model currently rates IDXX Greatly Underperform and A Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.